Zedsen

medical devices

About

Zedsen is a UK-based medical technology company dedicated to developing non-invasive, affordable, and portable medical devices for early breast cancer detection. Their flagship product, the Z-Scanner, utilizes Electrical Capacitance Tomography (ECT) along with advanced algorithms to deliver quantitative and clinically actionable screening results. This technology is particularly effective in analyzing dense breast tissue, which can be challenging for traditional methods. The company aims to decentralize healthcare by making their diagnostic tools available in general practitioner and community clinic settings, enhancing access to healthcare globally. Zedsen's mission aligns with improving care quality, population health, and reducing healthcare costs. The company is led by experienced executives Michael Lynch and Martin Harriman and is preparing to begin its first clinical study in late 2023. Founded in 2014 and headquartered in London, Zedsen employs between 11 and 50 people and operates in the medical equipment manufacturing sector.

Technologies

Outlook Microsoft Office 365 Amazon AWS Atlassian Cloud Google Tag Manager Mobile Friendly Remote AI

Keywords

sensors hardware firmware software innovation electronic design algorithms machine learning materials science testing data science data analysis cancer oncology medical equipment manufacturing portable diagnostic tool biotechnology portable medical device time-domain voltage response bio-impedance sensing early detection of dense tissue abnormalities breast cancer screening biosensing technology medical devices medical imaging technology medical equipment and supplies manufacturing dense tissue analysis early diagnosis b2b non-invasive cancer detection

Location

21a John Street, London, England, United Kingdom, WC1N 2BF

Related Companies

Companies in the same industry